Smart Money Group’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-31,469
Closed -$1.54M 59
2021
Q4
$1.54M Sell
31,469
-827
-3% -$41.1K 0.98% 27
2021
Q3
$1.64M Sell
32,296
-27,366
-46% -$1.41M 1.2% 25
2021
Q2
$2.83M Sell
59,662
-3,908
-6% -$206K 3.24% 12
2021
Q1
$3.33M Sell
63,570
-2,958
-4% -$165K 2.78% 12
2020
Q4
$3.54M Buy
66,528
+176
+0.3% +$9.03K 2.98% 12
2020
Q3
$3.16M Buy
66,352
+6,289
+10% +$293K 1.36% 26
2020
Q2
$2.85M Sell
60,063
-78
-0.1% -$3.48K 1.68% 20
2020
Q1
$2.25M Sell
60,141
-1,970
-3% -$81.5K 1.58% 20
2019
Q4
$2.7M Buy
62,111
+1,145
+2% +$46K 1.58% 16
2019
Q3
$2.19M Buy
60,966
+2,655
+5% +$102K 1.75% 14
2019
Q2
$2.39M Buy
58,311
+1,432
+3% +$59K 1.98% 13
2019
Q1
$2.55M Buy
56,879
+2,910
+5% +$122K 2.23% 13
2018
Q4
$1.88M Buy
53,969
+4,724
+10% +$180K 1.95% 17
2018
Q3
$2.24M Buy
49,245
+1,610
+3% +$72K 2.03% 16
2018
Q2
$2.09M Sell
47,635
-945
-2% -$40.1K 1.87% 20
2018
Q1
$2M Buy
48,580
+1,812
+4% +$76.3K 2.04% 19
2017
Q4
$1.9M Buy
+46,768
New +$1.87M 2.95% 11

Other funds holding BBP

Smart Money Group's BBP Position: Q1 2022 in Review

Smart Money Group sold out of Virtus Biotech ETF (BBP) in Q1 2022, closing a stake of 31,469 shares — an estimated $1.54M sold.

Smart Money Group first reported a position in BBP in Q4 2017 and held it in 17 quarters. The position peaked at $3.54M in Q4 2020. 11 funds tracked by Wall St. Rank hold BBP as of Q1 2022.

  • Smart Money Group reported no remaining Virtus Biotech ETF position as of Q1 2022 after selling out during the quarter.
  • Smart Money Group sold 31,469 Virtus Biotech ETF shares in Q1 2022, an estimated $1.54M.
  • Smart Money Group first reported a position in Virtus Biotech ETF in Q4 2017 and held it in 17 quarters.
  • Smart Money Group's Virtus Biotech ETF position peaked at $3.54M in Q4 2020.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2022.

Based on Smart Money Group's 13F filing for Q1 2022, filed 22 Apr 2022.